Dr. Edda Spiekerkoetter, MD is a Pulmonologist (Lung Specialist) - General practicing in Stanford, CA
She has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Freiburg | Medical Degree | Medicine | Not Specified |
| Institution | Focus | Year |
|---|---|---|
| Residency - Medizinische Hochschule Hannover, Germany | 2002 | |
| Fellowship - Stanford Hospital and Clinics - Critical Care CA | 2009 | |
| Fellowship - Stanford University CA | 2008 | |
| Fellowship - Lucile Packard Children's Hospital CA | 2006 |
| Distinction | Institution | Year |
|---|---|---|
| Cardiovascular Institute at Stanford | Manuscript Award | 2014 |
| Excellence Cluster Cardio-Pulmonary System (ECCPS) and Pulmonary Vasc | 2014 | |
| Helmholtz Zentrum Muenchen, Germany | Helmholtz International Research Group Award | 2013-2016 |
| Seed Grant- BMP signaling in the RV, Cardiovascular Institute Stanfor | 2013-2014 | |
| Seed Grant - Phase II Clinical Trial, Wall Center of Pulmonary Vascul | 2012-2014 | |
| Seed Grant - Phase II Clinical Trial, SPARK and Spectrum Stanford | 2012-2014 | |
| Seed Grant - Small Molecule High Throughout Screen, Wall Center of Pu | 2012 | |
| Winner of Poster competition, Cardiovascular Institute Stanford (Sept | 2012 | |
| Supplemental award of the Pulmonary Hypertension Association (PHA), P | 2011-2016 | |
| Pulmonary Hypertension Association | Postdoctoral Research Fellowship | 2003-2005 |
| NIH | K08 Career development award | 2011-2016 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | jourl of experimental medicine | Reduced BMPR2 expression induces GM | 2014 |
| Other Publication | Pulmory circulation | A case of recurrent pericardial constriction presenting with severe pulmory hypertension. | 2013 |
| Other Publication | The Jourl of clinical investigation | FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmory hypertension. | |
| Other Publication | Circulation research | Loss of adenomatous poliposis coli | 2012 |
| Other Publication | AMERICAN JOURL OF CARDIOLOGY | Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmory | 2012 |
| Other Publication | AMERICAN JOURL OF PATHOLOGY | Neutrophil Elastase Is Produced by Pulmory Artery Smooth Muscle Cells | 2011 |
| Other Publication | JOURL OF CELL BIOLOGY | BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt | 2011 |
| Other Publication | CIRCULATION RESEARCH | S100A4 and Bone Morphogenetic Protein | 2009 |
| Other Publication | AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | Reactivation of gamma HV68 induces neointimal lesions in pulmory arteries of S100A4 | 2008 |
| Other Publication | EUROPEAN RESPIRATORY JOURL | Experience with inhaled iloprost and bosentan in portopulmory hypertension | 2007 |
| Other Publication | CHEST | Mts1/S100A4 stimulates human pulmory artery smooth muscle cell migration through multiple sigling | 2005 |
| Other Publication | EUROPEAN RESPIRATORY JOURL | Goal-oriented treatment and combition therapy for pulmory arterial hypertension | 2005 |
| Other Publication | CIRCULATION RESEARCH | Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmory hypertension | 2005 |
| Other Publication | CIRCULATION RESEARCH | Interdependent serotonin transporter and receptor pathways regulate S100A4 | 2005 |
| Other Publication | EUROPEAN RESPIRATORY JOURL | Bosentan treatment in patients with primary pulmory hypertension receiving nonparenteral | 2003 |
| Other Publication | EUROPEAN RESPIRATORY JOURL | Effects of inhaled salbutamol in primary pulmory hypertension | 2002 |
| Other Publication | EUROPEAN RESPIRATORY JOURL | Intravenous iloprost for treatment failure of aerosolised iloprost in pulmory arterial hypertension | 2002 |
| Other Publication | Pneumologie (Stuttgart, Germany) | [Long-term treatment of primary pulmory hypertension with inhaled iloprost]. | 2001 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | Long-term treatment of primary pulmory hypertension with aerosolized iloprost | 2000 |
| Other Publication | TRANSPLANTATION PROCEEDINGS | Prevalence of maligncies after lung transplantation | 1998 |
Dr. Edda Spiekerkoetter, MD has not yet indicated the hospitals that she is affiliated with.
Accepts New Patients: Yes
Dr. Edda Spiekerkoetter, MD has not yet listed the medications that she commonly prescribes.
Dr. Edda Spiekerkoetter, MD has not yet added any information about her practice's billing policies and payment options.
